Loading...

Isidro B Salusky

Title(s)Professor, Pediatrics
SchoolMedicine
Address760 Westwood Plaza 12-311
Los Angeles CA 90024
Phone3102066987
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Phosphate binder therapy and chronic kidney disease in children
    NIH/NIDDK U01DK122013Jun 15, 2020 - Apr 30, 2025
    Role: Principal Investigator
    Phosphate Binders in Children with Chronic Kidney Disease-Mineral Bone Disorder
    NIH/NIDDK U34DK104619Aug 1, 2015 - Jul 31, 2016
    Role: Principal Investigator
    Translational Research Training in Pediatric Nephrology
    NIH/NIDDK T32DK104687Jul 1, 2015 - Jun 30, 2020
    Role: Principal Investigator
    UCLA Graduate Training Program in Translational and Clinical Investigation
    NIH/NCRR K30RR022259Aug 27, 2010 - May 31, 2011
    Role: Principal Investigator
    Role of Parathyroid Hormone in Renal Osteodystrophy
    NIH/NIDDK R01DK067563Feb 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    ENDOCHONDRAL BONE FORMATION IN RENAL FAILURE
    NIH/NIDDK R21DK053655Jan 1, 1998 - Dec 31, 1999
    Role: Principal Investigator
    Regulation of Bone Mineralization in Renal Osteodystrophy
    NIH/NIDDK R01DK035423Jan 1, 1986 - Jun 30, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis. Pediatr Nephrol. 2020 Jul 09. Sohn W, Salusky IB, Schmitt CP, Taylan C, Walle JV, Ngang J, Yan L, Kroenke M, Warady BA. PMID: 32647975.
      View in: PubMed   Mentions:    Fields:    
    2. Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. J Am Soc Nephrol. 2020 Jul 06. Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Jüppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, Collins MT. PMID: 32631973.
      View in: PubMed   Mentions:    Fields:    
    3. The Authors Reply. Kidney Int Rep. 2020 Jul; 5(7):1119-1120. Sharma S, Hanudel MR, Ix JH, Salusky IB, Ganz T, Nguyen KL. PMID: 32647775.
      View in: PubMed   Mentions:
    4. Measurement of serum phosphate levels using a mobile sensor. Analyst. 2020 Mar 02; 145(5):1841-1848. Ray A, Esparza S, Wu D, Hanudel MR, Joung HA, Gales B, Tseng D, Salusky IB, Ozcan A. PMID: 31960836.
      View in: PubMed   Mentions:    Fields:    
    5. Effects of erythropoietin on fibroblast growth factor 23 in mice and humans. Nephrol Dial Transplant. 2019 12 01; 34(12):2057-2065. Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard CAJM, Ganz T. PMID: 30007314.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    6. Unraveling the osteocyte in CKD-MBD post-renal transplantation. Kidney Int. 2019 11; 96(5):1059-1061. Laster M, Pereira RC, Salusky IB. PMID: 31648693.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients. Kidney Int Rep. 2019 Dec; 4(12):1742-1748. Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB. PMID: 31844811.
      View in: PubMed   Mentions:
    8. Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD. Kidney Int Rep. 2019 Dec; 4(12):1748-1751. Sharma S, Hanudel MR, Ix JH, Salusky IB, Ganz T, Nguyen KL. PMID: 31844812.
      View in: PubMed   Mentions:
    9. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Bone. 2019 10; 127:626-634. Pereira RC, Salusky IB, Bowen RE, Freymiller EG, Wesseling-Perry K. PMID: 31377240.
      View in: PubMed   Mentions:    Fields:    
    10. Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy. Pediatr Nephrol. 2019 10; 34(10):1799-1809. Okuda Y, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K. PMID: 31218394.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Racial differences in bone histomorphometry in children and young adults treated with dialysis. Bone. 2019 10; 127:114-119. Laster M, Pereira RC, Salusky IB. PMID: 31181383.
      View in: PubMed   Mentions:    Fields:    
    12. Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate). Drugs. 2019 Jun; 79(9):957-968. Ganz T, Bino A, Salusky IB. PMID: 31134521.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA. PMID: 30536181.
      View in: PubMed   Mentions:    Fields:    
    14. Non-renal-Related Mechanisms of FGF23 Pathophysiology. Curr Osteoporos Rep. 2018 12; 16(6):724-729. Hanudel MR, Laster M, Salusky IB. PMID: 30353318.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy. Kidney Int. 2018 11; 94(5):1002-1012. Pereira RC, Salusky IB, Roschger P, Klaushofer K, Yadin O, Freymiller EG, Bowen R, Delany AM, Fratzl-Zelman N, Wesseling-Perry K. PMID: 30348285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    16. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115. Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K. PMID: 30267239.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA. PMID: 30141180.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    18. Skeletal Consequences of Nephropathic Cystinosis. J Bone Miner Res. 2018 10; 33(10):1870-1880. Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT. PMID: 29905968.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients. Pediatr Nephrol. 2018 11; 33(11):2137-2142. Hanudel MR, Laster M, Ramos G, Gales B, Salusky IB. PMID: 29956006.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease. Haematologica. 2018 04; 103(4):e141-e142. Hanudel MR, Rappaport M, Chua K, Gabayan V, Qiao B, Jung G, Salusky IB, Ganz T, Nemeth E. PMID: 29419424.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    21. Erratum to "Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease" [Bone, 45(6) (2009) 1161-1168]. Bone. 2018 03; 108:210-211. Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. PMID: 29290423.
      View in: PubMed   Mentions:    Fields:    
    22. FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clin J Am Soc Nephrol. 2018 01 06; 13(1):45-52. Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA. PMID: 29025789.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    23. Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow. Haematologica. 2017 11; 102(11):e427-e430. Clinkenbeard EL, Hanudel MR, Stayrook KR, Appaiah HN, Farrow EG, Cass TA, Summers LJ, Ip CS, Hum JM, Thomas JC, Ivan M, Richine BM, Chan RJ, Clemens TL, Schipani E, Sabbagh Y, Xu L, Srour EF, Alvarez MB, Kacena MA, Salusky IB, Ganz T, Nemeth E, White KE. PMID: 28818868.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    24. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder. Curr Osteoporos Rep. 2017 06; 15(3):198-206. Hanudel MR, Salusky IB. PMID: 28455644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis. Am J Kidney Dis. 2017 Sep; 70(3):445-448. Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB. PMID: 28495360.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model. Haematologica. 2017 03; 102(3):e85-e88. Hanudel MR, Rappaport M, Gabayan V, Jung G, Salusky IB, Nemeth E, Ganz T, Zaritsky J. PMID: 27884972.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    27. Fibroblast growth factor 23: fueling the fire. Kidney Int. 2016 11; 90(5):928-930. Hanudel M, Jüppner H, Salusky IB. PMID: 27742194.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    28. Racial-ethnic disparities in mortality and kidney transplant outcomes among pediatric dialysis patients. Pediatr Nephrol. 2017 04; 32(4):685-695. Laster M, Soohoo M, Hall C, Streja E, Rhee CM, Ravel VA, Reddy U, Norris KC, Salusky IB, Kalantar-Zadeh K. PMID: 27796622.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Renal Physiol. 2016 12 01; 311(6):F1369-F1377. Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB. PMID: 27733366.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    30. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 11 07; 11(11):1989-1998. Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB. PMID: 27561289.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    31. MRI with ferumoxytol: A single center experience of safety across the age spectrum. J Magn Reson Imaging. 2017 03; 45(3):804-812. Nguyen KL, Yoshida T, Han F, Ayad I, Reemtsen BL, Salusky IB, Satou GM, Hu P, Finn JP. PMID: 27480885.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol. Pediatr Radiol. 2016 Aug; 46(9):1332-40. Luhar A, Khan S, Finn JP, Ghahremani S, Griggs R, Zaritsky J, Salusky I, Hall TR. PMID: 27059620.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Bone Canopies in Pediatric Renal Osteodystrophy. PLoS One. 2016; 11(4):e0152871. Pereira RC, Andersen TL, Friedman PA, Tumber N, Salusky IB, Wesseling-Perry K. PMID: 27045269.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Combining exercise and growth hormone therapy: how can we translate from animal models to chronic kidney disease children? Nephrol Dial Transplant. 2016 08; 31(8):1191-4. Bacchetta J, Salusky IB. PMID: 26908776.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    35. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry. Clin J Am Soc Nephrol. 2016 Mar 07; 11(3):481-7. Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K. PMID: 26712809.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients. Pediatr Nephrol. 2016 Apr; 31(4):661-9. Hanudel MR, Wesseling-Perry K, Gales B, Ramos G, Campbell V, Ethridge K, Scotti M, Elashoff DA, Alejos J, Reemtsen B, Salusky IB. PMID: 26525200.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation. PLoS One. 2015; 10(9):e0138156. Pereira RC, Valta H, Tumber N, Salusky IB, Jalanko H, Mäkitie O, Wesseling Perry K. PMID: 26390291.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    38. Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study. J Am Soc Nephrol. 2016 Feb; 27(2):543-50. Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA, Salusky IB, Warady BA, Furth SL, Leonard MB. PMID: 26139439.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    39. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. PLoS One. 2015; 10(3):e0120856. Pereira RC, Jüppner H, Gales B, Salusky IB, Wesseling-Perry K. PMID: 25774916.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    40. Dr. Ira Greifer. Pediatr Nephrol. 2015 Apr; 30(4):699-700. Kaskel F, Salusky IB. PMID: 25620539.
      View in: PubMed   Mentions:    Fields:    
    41. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One. 2014; 9(12):e116530. Bacchetta J, Chun RF, Gales B, Zaritsky JJ, Leroy S, Wesseling-Perry K, Boregaard N, Rastogi A, Salusky IB, Hewison M. PMID: 25549329.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    42. Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo. Kidney Int. 2015 Mar; 87(3):593-601. Pereira RC, Delany AM, Khouzam NM, Bowen RE, Freymiller EG, Salusky IB, Wesseling-Perry K. PMID: 25354236.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    43. Four-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart: a feasibility study in children. Magn Reson Med. 2015 Oct; 74(4):1042-9. Han F, Rapacchi S, Khan S, Ayad I, Salusky I, Gabriel S, Plotnik A, Finn JP, Hu P. PMID: 25302932.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    44. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort. Pediatr Nephrol. 2015 Mar; 30(3):515-21. Nayak AB, Luhar A, Hanudel M, Gales B, Hall TR, Finn JP, Salusky IB, Zaritsky J. PMID: 25212105.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    45. Cortical and trabecular bone in pediatric end-stage kidney disease. Pediatr Nephrol. 2015 Mar; 30(3):497-502. Carvalho CG, Pereira RC, Gales B, Salusky IB, Wesseling-Perry K. PMID: 25185885.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. The role of bone in CKD-mediated mineral and vascular disease. Pediatr Nephrol. 2015 Sep; 30(9):1379-88. Khouzam NM, Wesseling-Perry K, Salusky IB. PMID: 25168424.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab. 2014 Oct; 99(10):E1951-6. Wesseling-Perry K, Wang H, Elashoff R, Gales B, Jüppner H, Salusky IB. PMID: 25062462.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    48. The accuracy of a continuous volumetric balancing system in pediatric continuous renal replacement therapy. Int J Artif Organs. 2014 Mar; 37(3):215-21. Hanudel MR, Salusky IB, Zaritsky JJ. PMID: 24744166.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    49. FGF23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol Dial Transplant. 2014 Aug; 29(8):1525-32. van Venrooij NA, Pereira RC, Tintut Y, Fishbein MC, Tumber N, Demer LL, Salusky IB, Wesseling-Perry K. PMID: 24459137.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol. 2014 Feb; 9(2):344-53. Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB. PMID: 24311704.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    51. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014 Mar; 25(3):564-72. Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K, Nayak A, Wesseling-Perry K, Westerman M, Hollis BW, Salusky IB, Hewison M. PMID: 24204002.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    52. Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):437-41. Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, Chow G, Gales B, Salusky IB, Wesseling-Perry K. PMID: 24009282.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. FGF23 and mineral metabolism in the early post-renal transplantation period. Pediatr Nephrol. 2013 Nov; 28(11):2207-15. Wesseling-Perry K, Pereira RC, Tsai E, Ettenger R, Jüppner H, Salusky IB. PMID: 23852336.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol. 2013 May; 8(5):824-32. Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB. PMID: 23559676.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    55. Chronic kidney disease: mineral and bone disorder in children. Semin Nephrol. 2013 Mar; 33(2):169-79. Wesseling-Perry K, Salusky IB. PMID: 23465503.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    56. Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. Pediatr Rheumatol Online J. 2013; 11:6. Bacchetta J, Wesseling-Perry K, Gilsanz V, Gales B, Pereira RC, Salusky IB. PMID: 23418950.
      View in: PubMed   Mentions: 4     Fields:    
    57. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children. Pediatr Nephrol. 2013 Apr; 28(4):617-25. Wesseling-Perry K, Salusky IB. PMID: 23381010.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25. Li J, Molnar MZ, Zaritsky JJ, Sim JJ, Streja E, Kovesdy CP, Salusky I, Kalantar-Zadeh K. PMID: 23348879.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    59. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res. 2013 Jan; 28(1):46-55. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M. PMID: 22886720.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    60. Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity? Pediatr Nephrol. 2013 Apr; 28(4):577-82. Bacchetta J, Salusky IB, Hewison M. PMID: 23117582.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    61. Nutritional vitamin D use in chronic kidney disease: a survey of pediatric nephrologists. Pediatr Nephrol. 2013 Feb; 28(2):265-75. Griffin LM, Denburg MR, Shults J, Furth SL, Salusky IB, Hwang W, Leonard MB. PMID: 23086591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9. Miller JE, Molnar MZ, Kovesdy CP, Zaritsky JJ, Streja E, Salusky I, Arah OA, Kalantar-Zadeh K. PMID: 22996597.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    63. The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant. 2012 Aug; 27(8):3063-71. Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K. PMID: 22851629.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    64. An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects. Pediatr Nephrol. 2012 Oct; 27(10):1953-9. Padhi D, Langman CB, Fathallah-Shaykh S, Warady BA, Salusky IB, Lee E, Wang C, Posvar E. PMID: 22639045.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    65. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 2012 Apr; 23(4):727-38. Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, Kendrick CA, James SH, Miller BW, Schulman G, Salusky IB, Kliger AS. PMID: 22362907.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    66. Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function. Pediatr Nephrol. 2012 Jul; 27(7):1131-8. Bacchetta J, Cochat P, Salusky IB, Wesseling-Perry K. PMID: 22311343.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. Evaluation of hypophosphatemia: lessons from patients with genetic disorders. Am J Kidney Dis. 2012 Jan; 59(1):152-9. Bacchetta J, Salusky IB. PMID: 22075221.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012 Jan; 7(1):146-52. Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, Jüppner H, Salusky IB. PMID: 22052943.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    69. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23? Nephrol Dial Transplant. 2011 Nov; 26(11):3779-84. Wesseling-Perry K, Tsai EW, Ettenger RB, Jüppner H, Salusky IB. PMID: 21441401.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    70. FGF-23: More than a regulator of renal phosphate handling? J Bone Miner Res. 2010 Oct; 25(10):2091-7. Jüppner H, Wolf M, Salusky IB. PMID: 20593414.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    71. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int. 2011 Jan; 79(1):112-9. Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, Jüppner H, Salusky IB. PMID: 20861820.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    72. Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. Pediatr Nephrol. 2010 Nov; 25(11):2311-9. Rianthavorn P, Ettenger RB, Salusky IB, Kuizon BD. PMID: 20676692.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    73. Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1860-6. Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB. PMID: 20634327.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    74. Ironing out the phosphorus problem. Kidney Int. 2010 May; 77(10):845-7. Zaritsky JJ, Salusky IB. PMID: 20431575.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84). J Clin Endocrinol Metab. 2010 Jun; 95(6):2772-80. Wesseling-Perry K, Harkins GC, Wang HJ, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Jüppner H, Salusky IB. PMID: 20382692.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    76. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1010-4. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. PMID: 20299375.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    77. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab. 2010 Feb; 95(2):578-85. Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Jüppner H. PMID: 19965919.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    78. Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient. Pediatr Nephrol. 2010 Feb; 25(2):357-62. Amin N, Gonzalez E, Lieber M, Salusky IB, Zaritsky JJ. PMID: 19885686.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    79. Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients. Pediatr Nephrol. 2010 Feb; 25(2):373-5. Gonzalez E, Schomberg J, Amin N, Salusky IB, Zaritsky J. PMID: 19876653.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone. 2009 Dec; 45(6):1161-8. Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. PMID: 19679205.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    81. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009 Nov; 76(9):977-83. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC. PMID: 19657329.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    82. Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens. 2009 Jul; 18(4):308-14. Wesseling-Perry K, Salusky IB. PMID: 19458529.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    83. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jun; 4(6):1051-6. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. PMID: 19406957.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    84. Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatr Nephrol. 2009 Jul; 24(7):1355-61. Wesseling-Perry K, Harkins GC, Wang HJ, Sahney S, Gales B, Elashoff RM, Jüppner H, Salusky IB. PMID: 19301038.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    85. A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infants. Pediatr Nephrol. 2009 Jul; 24(7):1263-6. Langman CB, Alon U, Ingelfinger J, Englund M, Saland JM, Somers MJ, Stapleton FB, Sibú NO, Cochat P, Wong W, Eke FU, Satlin L, Salusky I. PMID: 19198884.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    86. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab. 2009 Feb; 94(2):511-7. Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Jüppner H, Salusky IB. PMID: 19050056.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    87. Technical approach to iliac crest biopsy. Clin J Am Soc Nephrol. 2008 Nov; 3 Suppl 3:S164-9. Hernandez JD, Wesseling K, Pereira R, Gales B, Harrison R, Salusky IB. PMID: 18988702.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    88. Vascular access complications in long-term pediatric hemodialysis patients. Pediatr Nephrol. 2008 Nov; 23(11):2061-5. Zaritsky JJ, Salusky IB, Gales B, Ramos G, Atkinson J, Allsteadt A, Brandt ML, Goldstein SL. PMID: 18712416.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    89. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1144-51. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. PMID: 18417740.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    90. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis. 2008 Mar; 51(3):455-62. Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F. PMID: 18295061.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    91. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol. 2008 Feb; 23(2):195-207. Wesseling K, Bakkaloglu S, Salusky I. PMID: 18046581.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    92. Vitamin D therapy in children on dialysis. Perit Dial Int. 2007 Nov-Dec; 27(6):651-3. Wesseling K, Salusky IB. PMID: 17984426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis. 2007 Jun; 49(6):814-23. Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB. PMID: 17533024.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    94. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol. Nat Clin Pract Nephrol. 2007 Apr; 3(4):227-32. Hernandez JD, Wesseling K, Boechat MI, Gales B, Salusky IB. PMID: 17389892.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    95. A new era in phosphate binder therapy: what are the options? Kidney Int Suppl. 2006 Dec; (105):S10-5. Salusky IB. PMID: 17136110.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Current treatment options in secondary hyperparathyroidism. Nephrol Dial Transplant. 2006 Oct; 21(10):2986-7; author reply 2989-90. Wesseling K, Salusky IB. PMID: 16861736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol. 2006 Jan; 21(1):14-25. Chesney RW, Brewer E, Moxey-Mims M, Watkins S, Furth SL, Harmon WE, Fine RN, Portman RJ, Warady BA, Salusky IB, Langman CB, Gipson D, Scheidt P, Feldman H, Kaskel FJ, Siegel NJ. PMID: 16252095.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    98. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial. 2005 Jul-Aug; 18(4):290-5. Hernandez JD, Wesseling K, Salusky IB. PMID: 16076350.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005 Aug; 16(8):2501-8. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. PMID: 15944337.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    100. Calcification of the coronary arteries in the absence of atherosclerotic plaque. Mayo Clin Proc. 2005 Jun; 80(6):807-9. Qiao JH, Doherty TM, Fishbein MC, Salusky IB, Luthringer DL, Fitzpatrick LA, Shah PK, Rajavashisth TB. PMID: 15948300.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    101. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol. 2005 May; 20(5):622-30. Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB. PMID: 15785941.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    102. Are new vitamin D analogues in renal bone disease superior to calcitriol? Pediatr Nephrol. 2005 Mar; 20(3):393-8. Salusky IB. PMID: 15690188.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. New PTH assays and renal osteodystrophy. Pediatr Nephrol. 2004 Jul; 19(7):709-13. Salusky IB, Jüppner H. PMID: 15173936.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004 Mar; 43(3):558-65. Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L. PMID: 14981615.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    105. Bone histology in steroid-treated children with non-azotemic nephrotic syndrome. Pediatr Nephrol. 2004 Apr; 19(4):400-7. Freundlich M, Jofe M, Goodman WG, Salusky IB. PMID: 14991389.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    106. Special aspects of renal osteodystrophy in children. Semin Nephrol. 2004 Jan; 24(1):69-77. Salusky IB, Kuizon BG, Jüppner H. PMID: 14730512.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol. 2003 Dec; 18(12):1260-4. Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB. PMID: 14586677.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    108. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int. 2003 May; 63(5):1801-8. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Jüppner H. PMID: 12675856.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    109. Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol. 2003 Jun; 18(6):554-9. Lima EM, Goodman WG, Kuizon BD, Gales B, Emerick A, Goldin J, Salusky IB. PMID: 12712376.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    110. Outcome of slipped capital femoral epiphysis in renal osteodystrophy. J Pediatr Orthop. 2003 Mar-Apr; 23(2):169-74. Oppenheim WL, Bowen RE, McDonough PW, Funahashi TT, Salusky IB. PMID: 12604945.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    111. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int. 2003 Jan; 63(1):1-11. Goodman WG, Jüppner H, Salusky IB, Sherrard DJ. PMID: 12472763.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments. Nephrol Dial Transplant. 2002 Oct; 17(10):1731-6. Goodman WG, Salusky IB, Jüppner H. PMID: 12270977.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    113. Cell biology of renal osteodystrophy. Pediatr Nephrol. 2002 Oct; 17(10):777-89. Kuizon BD, Salusky IB. PMID: 12376803.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    114. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J Am Soc Nephrol. 2002 Jun; 13(6):1490-8. Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Drüeke TB, Sarfati E, Ureña P, Chaganti RS, Arnold A. PMID: 12039978.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    115. Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatr Nephrol. 2002 May; 17(5):322-8. Sanchez CP, Kuizon BD, Goodman WG, Gales B, Ettenger RB, Boechat MI, Wang Y, Elashoff R, Salusky IB. PMID: 12042887.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    116. Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant. 2002 Feb; 17(2):336-9. Salusky IB, Goodman WG. PMID: 11812902.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    117. Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol. 2001 Sep; 12(9):1978-85. Salusky IB, Goodman WG. PMID: 11518793.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    118. Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism. Pediatr Nephrol. 2000 Jul; 14(7):641-5. Salusky IB, Goodman WG, Kuizon BD. PMID: 10912534.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals